The board at Acadia must look at NEU , wondering how to get their hands on the NNZ2591 and clean up the DAYBUE deal.
A specialist CNS company needs specialist CNS drugs. 2591 would be like owning the Crown Jewels.
I would not count them out ! With a gun CEO, full of energy wanting to make her mark on the world. It’s hard to see she has come over to ACAD just to launch Daybue in Canada, Europe and Japan.
That seems a small strategy for someone to grow their reputation.
Acadia, page-872
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.13 |
Change
0.020(0.15%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.44 | $13.07 | $5.021M | 378.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 11501 | $13.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.18 | 1539 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |